Wave Life Sciences

Wave Life Sciences

Biotechnology, 733 Concord Ave, Cambridge, Massachusetts, 02138, United States, 201-500 Employees

wavelifesciences.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 16*********

Who is WAVE LIFE SCIENCES

Wave Life Sciences is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Our RNA medicines platform, PRISM, combines multiple mod...

Read More

map
  • 733 Concord Ave, Cambridge, Massachusetts, 02138, United States Headquarters: 733 Concord Ave, Cambridge, Massachusetts, 02138, United States
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $50 Million to $100 Million

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from WAVE LIFE SCIENCES

Wave Life Sciences Org Chart and Mapping

Employees

Wei Liu

Senior Scientist II

Brenda Goguen

Senior Director, New Product Planning & Corporate Strategy

Khan Mohammad

Director of IT Operations

Marina Freytsis

Director, Alliance Management and Business Development

Madhuri Agarwal

Director Global Regulatory Affairs

Krista Condon

Director, Preclinical Outsourcing

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Wave Life Sciences

Answer: Wave Life Sciences's headquarters are located at 733 Concord Ave, Cambridge, Massachusetts, 02138, United States

Answer: Wave Life Sciences's phone number is 16*********

Answer: Wave Life Sciences's official website is https://wavelifesciences.com

Answer: Wave Life Sciences's revenue is $50 Million to $100 Million

Answer: Wave Life Sciences's SIC: 2834

Answer: Wave Life Sciences has 201-500 employees

Answer: Wave Life Sciences is in Biotechnology

Answer: Wave Life Sciences contact info: Phone number: 16********* Website: https://wavelifesciences.com

Answer: Wave Life Sciences is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Our RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Our toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing us with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Our diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency and Huntingtons disease, as well as a preclinical program in obesity. Driven by the calling to Reimagine Possible, we are leading the charge toward a world in which human potential is no longer hindered by the burden of disease.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access